Clinical Trial Research
Transdel Pharmaceuticals Provides Update on Timing of Results for Phase 3 Study
Published in Food and Drug Law Weekly, July 3rd, 2009
The Phase 3 study consists of a randomized, double-blind, placebo controlled trial to evaluate the efficacy and safety of Ketotransdel, a topical cream based non-steroidal anti-inflammatory drug ("NSAID"), in acute soft tissue injuries of the upper and lower extremities. The multi-center trial is being conducted at approximately 30 sites in the United States and will enroll...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
More Articles from Food and Drug Law Weekly
- Adverse Drug Reactions
Hydroxycut(R) Litigation Focus of July 28 Conference in San Francisco - American College of Chest Physicians
American College of Chest Physicians Celebrates the Nation's Victory for Tobacco Control - American Frozen Food Institute AFFI
American Frozen Food Institute Calls on House Committee to Make Necessary Revisions to Upcoming Food Safety Legislation - American Physical Therapy Association
Loan Repayment Legislation Includes Physical Therapists as Frontline Providers - Blood Cancer
The Leukemia & Lymphoma Society Calls for Blood Cancer Research Program at the Department of Defense - Cancer
Lung Cancer Alliance Issues Statement on FDA Tobacco Regulation Bill - More from this issue of Food and Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
